Yan-Ruide Li

机构：University of California, Los Angeles · ORCID：0000-0002-9858-300X

发表论文 6 篇 · 总被引 226 次 · h-index 4

代表论文

• Targeting monoamine oxidase A for T cell–based cancer immunotherapy (2021 · Science Immunology · 被引 79)
• Serotonin transporter inhibits antitumor immunity through regulating the intratumoral serotonin axis (2025 · Cell · 被引 78)
• Overcoming ovarian cancer resistance and evasion to CAR-T cell therapy by harnessing allogeneic CAR-NKT cells (2025 · Med · 被引 48)
• Allogeneic stem cell-engineered EGFRvIII-specific CAR-NKT cells for treating glioblastoma with enhanced efficacy and safety (2025 · Molecular Therapy · 被引 20)
• 54Allogeneic HSPC-engineered CD70-directed CAR-NKT cells for renal cell carcinoma targeting tumor, microenvironment, and alloreactive T cells (2025 · The Oncologist · 被引 2)
• 29 Engineering CD16-Enhanced Stem Cell–Derived Universal NKT Cells to Potentiate Anti-CD70 Therapy in Renal Cell Carcinoma (2026 · The Oncologist)